Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Osteoporosis indication for tiludronate dropped

Sep. 25, 1997

Spotlight on bisphosphonates in osteoporosis

Sep. 25, 1997

Novo Nordisk presents potassium channel openers/blockers

Sep. 25, 1997

Study results of Crinone as ART treatment presented

Sep. 24, 1997

Acute vasodilating effects of KDI-792 in diabetics

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Abbott searches for squalene synthase inhibitors as hypolipidemics

Sep. 23, 1997

Novel progestins described by Gedeon Richter

Sep. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...